Please check your internet connection and try again.
# Lorazepam (Representative Benzodiazepine)
## Overview
Lorazepam is a benzodiazepine with anxiolytic, sedative, hypnotic, amnestic, and anticonvulsant properties. It acts as a positive allosteric modulator of the GABA-A receptor, enhancing inhibitory neurotransmission.
## Primary Indications
* Insomnia
* Anxiety disorders
* Seizures (status epilepticus)
* Preoperative sedation
* Management of alcohol withdrawal
## Adult Dosing
* **Anxiety:** 0.5-2 mg orally every 6-8 hours. Maximum recommended dose is typically 10 mg per day, but higher doses may be used short-term under close supervision.
* **Insomnia:** 2-4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg intravenously or intramuscularly. May repeat in 5-10 minutes if seizures persist. Maximum initial dose is 8 mg.
* **Preoperative Sedation:** 2-4 mg intramuscularly 2 hours before surgery.
* **Alcohol Withdrawal:** 2-4 mg orally or intravenously/intramuscularly every 4-6 hours as needed. Dosing is highly individualized and may be tapered.
*Note: Oral and intramuscular doses may differ. Intravenous administration is preferred for status epilepticus due to faster onset of action.*
## Pediatric Dosing
Dosing in pediatric patients is less established and should be guided by institutional protocols and expert consultation.
* **Anxiety/Sedation:** Typically initiated at lower doses than adults, with careful titration. For example, 0.02-0.05 mg/kg/dose IV/IM/PO every 6-8 hours. Maximum doses vary widely by age and indication.
* **Status Epilepticus:** 0.1 mg/kg/dose IV, not to exceed 4 mg per dose. May be repeated once after 5-10 minutes.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; dose reduction may be necessary.
* **Renal Impairment:** No specific dose adjustment recommended, but use with caution as clearance may be reduced.
* **Elderly:** Initiate at lower doses (e.g., 0.5 mg orally once or twice daily) and titrate cautiously due to increased sensitivity and risk of adverse effects like confusion and falls.
## Contraindications
* Known hypersensitivity to benzodiazepines or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Sleep apnea.
## Adverse Effects
Common: Drowsiness, dizziness, fatigue, ataxia, weakness, confusion.
Less common: Hypotension, respiratory depression (especially with IV administration or in combination with other CNS depressants), paradoxical excitation, amnesia, paradoxical reactions (agitation, rage).
## Key Drug Interactions
* **CNS Depressants (opioids, alcohol, other sedatives/hypnotics, antihistamines):** Additive CNS depression, increased risk of sedation, respiratory depression, coma, and death. Use together requires careful consideration and monitoring.
* **CYP Enzyme Inhibitors/Inducers:** Lorazepam is primarily metabolized by glucuronidation, not significant CYP450 metabolism, so fewer significant interactions compared to other benzodiazepines.
* **Theophylline/Aminophylline:** May antagonize the sedative effects of lorazepam.
## Monitoring
* Level of sedation, respiratory rate, and oxygen saturation, especially with parenteral administration or high doses.
* Mental status and cognitive function.
* Signs of withdrawal upon discontinuation.
* Fall risk, particularly in elderly patients.
## Clinical Pearls
* Avoid abrupt discontinuation; taper dose gradually to minimize withdrawal symptoms.
* Intramuscular absorption can be slow and erratic; intravenous administration is preferred for rapid onset.
* Pregnancy: Risk of floppy infant syndrome and withdrawal symptoms in newborns. Should be used only if clearly needed and benefits outweigh risks.
* Lactation: Lorazepam is excreted in breast milk; caution advised.
***
*Disclaimer: This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions.*
